Ascentage Pharma Group International (AAPG) Retained Earnings: 2023-2024
- Ascentage Pharma Group International's Retained Earnings fell 6.09% to -$790.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$790.6 million, marking a year-over-year decrease of 6.09%. This contributed to the annual value of -$790.6 million for FY2024, which is 4.13% down from last year.
- According to the latest figures from Q4 2024, Ascentage Pharma Group International's Retained Earnings is -$790.6 million, which was down 6.09% from -$745.1 million recorded in Q4 2023.
- In the past 5 years, Ascentage Pharma Group International's Retained Earnings registered a high of -$745.1 million during Q4 2023, and its lowest value of -$790.6 million during Q4 2024.
- Moreover, its 2-year median value for Retained Earnings was -$767.9 million (2023), whereas its average is -$767.9 million.
- Data for Ascentage Pharma Group International's Retained Earnings shows a maximum YoY declined of 6.09% (in 2024) over the last 5 years.
- Ascentage Pharma Group International's Retained Earnings (Quarterly) stood at -$745.1 million in 2023, then decreased by 6.09% to -$790.6 million in 2024.
